These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10619651)

  • 1. TRH increases cerebrospinal fluid concentration of kynurenine.
    Takeuchi Y; Matsushita H; Kawano H; Sakai H; Yoshimoto K; Sawada T
    Neuroreport; 1999 Nov; 10(17):3601-3. PubMed ID: 10619651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin-releasing hormone in treatment of intractable epilepsy: neurochemical analysis of CSF monoamine metabolites.
    Takeuchi Y; Tominaga M; Mitsufuji N; Yamazoe I; Kawase S; Nishimura A; Matsuo S; Sawada T
    Pediatr Neurol; 1995 Feb; 12(2):139-45. PubMed ID: 7540012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin-releasing hormone: role in the treatment of West syndrome and related epileptic encephalopathies.
    Takeuchi Y; Takano T; Abe J; Takikita S; Ohno M
    Brain Dev; 2001 Nov; 23(7):662-7. PubMed ID: 11701274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on kynurenine in human cerebrospinal fluid: lowered levels in epilepsy.
    Young SN; Joseph MH; Gauthier S
    J Neural Transm; 1983; 58(3-4):193-204. PubMed ID: 6198458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on CSF tryptophan metabolism in infantile spasms.
    Yamamoto H
    Pediatr Neurol; 1991; 7(6):411-4. PubMed ID: 1724601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in CSF tryptophan metabolite levels in infantile spasms].
    Yamamoto H; Egawa B; Horiguchi K; Kaku A; Yamada K
    No To Hattatsu; 1992 Nov; 24(6):530-5. PubMed ID: 1419165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of thyrotropin-releasing hormone for severe epilepsy in childhood: a comparative study with ACTH therapy.
    Matsumoto A; Kumagai T; Takeuchi T; Miyazaki S; Watanabe K
    Epilepsia; 1987; 28(1):49-55. PubMed ID: 3024959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures.
    Heyes MP; Saito K; Devinsky O; Nadi NS
    Epilepsia; 1994; 35(2):251-7. PubMed ID: 8156942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in CSF neurotransmitters in infantile spasms.
    Langlais PJ; Wardlow ML; Yamamoto H
    Pediatr Neurol; 1991; 7(6):440-5. PubMed ID: 1724602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin-releasing hormone in the treatment of intractable epilepsy.
    Kubek MJ; Garg BP
    Pediatr Neurol; 2002 Jan; 26(1):9-17. PubMed ID: 11814729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kynurenic acid is decreased in cerebrospinal fluid of patients with infantile spasms.
    Yamamoto H; Shindo I; Egawa B; Horiguchi K
    Pediatr Neurol; 1994 Feb; 10(1):9-12. PubMed ID: 8198681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on cerebrospinal fluid kynurenic acid concentrations in epileptic children.
    Yamamoto H; Murakami H; Horiguchi K; Egawa B
    Brain Dev; 1995; 17(5):327-9. PubMed ID: 8579218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental changes in cerebrospinal fluid concentrations of monoamine-related substances revealed with a Coulochem electrode array system.
    Takeuchi Y; Matsushita H; Sakai H; Kawano H; Yoshimoto K; Sawada T
    J Child Neurol; 2000 Apr; 15(4):267-70. PubMed ID: 10805197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study on the anticonvulsive effects of a thyrotropin-releasing hormone analog in intractable epilepsy.
    Matsuishi T; Yano E; Inanaga K; Terasawa K; Ishihara O; Shiotsuki Y; Katafuchi Y; Aoki N; Yamashita F
    Brain Dev; 1983; 5(4):421-8. PubMed ID: 6416101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable.
    Demitrack MA; Heyes MP; Altemus M; Pigott TA; Gold PW
    Biol Psychiatry; 1995 Apr; 37(8):512-20. PubMed ID: 7542489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of vagus nerve stimulation on tryptophan metabolites in children with intractable epilepsy.
    Klinkenberg S; van den Borne CJ; Aalbers MW; Verschuure P; Kessels AG; Leenen L; Rijkers K; Aldenkamp AP; Vles JS; Majoie HJ
    Epilepsy Behav; 2014 Aug; 37():133-8. PubMed ID: 25022821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
    Rajput SK; Krishnamoorthy S; Pawar C; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
    Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of progressive myoclonus epilepsy with TRH.
    Tanaka C; Maegaki Y; Koeda T; Ohta S; Takeshita K
    Pediatr Neurol; 1998 May; 18(5):442-4. PubMed ID: 9650689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria.
    Holmberg D; Franzén-Röhl E; Idro R; Opoka RO; Bangirana P; Sellgren CM; Wickström R; Färnert A; Schwieler L; Engberg G; John CC
    Malar J; 2017 Jul; 16(1):303. PubMed ID: 28754152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.